VOR Stock Analysis: Buy, Sell, or Hold?
VOR - Vor Biopharma Inc. Common Stock
$20.59
2.20 (11.96%)
▲
5d:
+37.91%
30d:
+50.73%
90d:
+18.4%
WAIT
LOW Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Get Alerted When VOR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: VOR is 22.1% above its trading range ($16.87). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: VOR is 22.1% above its trading range ($16.87). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: VOR is currently trading at $20.59, which is considered extended relative to its 30-day fair value range of $13.19 to $16.87.
Technical Outlook: Technically, VOR is in a strong uptrend. Immediate support is located at $14.22, while resistance sits at $22.22. The stock is showing strong short-term momentum, up 12.0% recently.
Market Sentiment: VOR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $37.88 (+83.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VOR is in a strong uptrend. Immediate support is located at $14.22, while resistance sits at $22.22. The stock is showing strong short-term momentum, up 12.0% recently.
Market Sentiment: VOR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $37.88 (+83.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$13.19 -
$16.87
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price significantly overextended (+22.1% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+12.0%)
- BULLISH: Trading 83.9% below Wall St target ($37.88)
- WARNING: Recommendation downgraded due to 22.1% overvaluation
Trading Range Analysis
30-Day Trading Range
$13.19 -
$16.87
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$14.22
Resistance Level
$22.22
Current Trend
Strong Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.50
Wall Street Target
$37.88
(+83.9%)
Share & Embed Analysis
Last updated: July 02, 2026 9:39 PM ET
Data refreshes hourly during market hours. Next update: 10:39 PM
Data refreshes hourly during market hours. Next update: 10:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VOR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
11
Sells
Net
INSIDERS SELLING
Recent Transactions
Ra Capital Management, L…
SELL
165150 shares
2026-04-22
Ra Capital Management, L…
SELL
171963 shares
2026-04-20
Ra Capital Management, L…
SELL
458411 shares
2026-04-17
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 59 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$257 | 61 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 58 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$51 | 62 BUY |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 61 BUY |
